Drug and Narcotic Control
"Drug and Narcotic Control" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.
| Descriptor ID |
D004335
|
| MeSH Number(s) |
I01.880.604.605.250 N03.706.615.402.250 N04.452.706.310
|
| Concept/Terms |
Pharmaceutical Policy- Pharmaceutical Policy
- Pharmaceutical Policies
- Policies, Pharmaceutical
- Policy, Pharmaceutical
- Pharmaceutic Policy
Narcotic Control- Narcotic Control
- Control, Narcotic
- Controls, Narcotic
- Narcotic Controls
Drug Control- Drug Control
- Control, Drug
- Controls, Drug
- Drug Controls
Drug Regulations- Drug Regulations
- Drug Regulation
- Regulation, Drug
- Regulations, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug and Narcotic Control".
Below are MeSH descriptors whose meaning is more specific than "Drug and Narcotic Control".
This graph shows the total number of publications written about "Drug and Narcotic Control" by people in this website by year, and whether "Drug and Narcotic Control" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 9 | 6 | 15 |
| 2018 | 11 | 2 | 13 |
| 2019 | 3 | 3 | 6 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug and Narcotic Control" by people in Profiles.
-
Japan's Special Approval for Emergency System During the COVID-19 Pandemic. Clin Pharmacol Ther. 2022 03; 111(3):551-558.
-
From sandbox to pandemic: Agile reform of Canadian drug regulation. Health Policy. 2021 09; 125(9):1115-1120.
-
"It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care. Contraception. 2021 07; 104(1):67-72.
-
Common themes in early state policy responses to substance use disorder treatment during COVID-19. Am J Drug Alcohol Abuse. 2021 07 04; 47(4):486-496.
-
Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic. Contraception. 2021 07; 104(1):111-116.
-
An introduction to risk evaluation and mitigation strategies. Contraception. 2021 07; 104(1):4-7.
-
Abortion exceptionalism and the mifepristone REMS. Contraception. 2021 07; 104(1):8-11.
-
Regulatory status quo and prospects for biosurfactants in pharmaceutical applications. Drug Discov Today. 2021 08; 26(8):1929-1935.
-
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries. Am J Cardiovasc Drugs. 2021 09; 21(5):581-583.
-
Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand. Arthritis Rheumatol. 2021 05; 73(5):896-897.